COLUMBIA, Md., Dec. 2 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced that it intends to release the results of its fourth quarter and fiscal year 2008 on December 11, 2008, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference call to discuss these results with investors. All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.
An archived webcast of the conference call will be available on the Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 21403979.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA, a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life'sARA (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.
Contact: Kyle Stults Investor Relations (410) 740-0081 Cassie France-Kelly Public Relations (410) 740-0081
|SOURCE Martek Biosciences Corporation|
Copyright©2008 PR Newswire.
All rights reserved